Works about LINEZOLID

Results: 1329
    1
    2
    3
    4
    5
    6
    7

    SSRIs and linezolid interaction.

    Published in:
    Brown University Psychopharmacology Update, 2018, v. 29, n. 6, p. 2, doi. 10.1002/pu.30328
    By:
    • Lam, Y. W. Francis
    Publication type:
    Article
    8
    9
    10

    Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1067, doi. 10.3390/jcm9041067
    By:
    • Simon, Philipp;
    • Busse, David;
    • Petroff, David;
    • Dorn, Christoph;
    • Ehmann, Lisa;
    • Hochstädt, Sophie;
    • Girrbach, Felix;
    • Dietrich, Arne;
    • Zeitlinger, Markus;
    • Kees, Frieder;
    • Kloft, Charlotte;
    • Wrigge, Hermann
    Publication type:
    Article
    11
    12

    Impact of added copper, alone or in combination with chlortetracycline, on growth performance and antimicrobial resistance of fecal enterococci of weaned piglets.

    Published in:
    Journal of Animal Science, 2020, v. 98, n. 3, p. N.PAG, doi. 10.1093/jas/skaa003
    By:
    • Capps, Kaylen M;
    • Amachawadi, Raghavendra G;
    • Menegat, Mariana B;
    • Woodworth, Jason C;
    • Perryman, Kurt;
    • Tokach, Mike D;
    • Dritz, Steve S;
    • DeRouchey, Joel M;
    • Goodband, Robert D;
    • Bai, Jianfa;
    • Apley, Mike D;
    • Lubbers, Brian V;
    • Nagaraja, Tiruvoor G
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50781-4
    By:
    • Strydom, Natasha;
    • Ernest, Jacqueline P.;
    • Imperial, Marjorie;
    • Solans, Belén P.;
    • Wang, Qianwen;
    • Tasneen, Rokeya;
    • Tyagi, Sandeep;
    • Soni, Heena;
    • Garcia, Andrew;
    • Bigelow, Kristina;
    • Gengenbacher, Martin;
    • Zimmerman, Matthew;
    • Xie, Min;
    • Sarathy, Jansy P.;
    • Yang, Tian J.;
    • Dartois, Véronique;
    • Nuermberger, Eric L.;
    • Savic, Radojka M.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

    Published in:
    2019
    By:
    • Lee, Myungsun;
    • Mok, Jeongha;
    • Kim, Deog Kyeom;
    • Shim, Tae Sun;
    • Koh, Won-Jung;
    • Jeon, Doosoo;
    • Lee, Taehoon;
    • Lee, Seung Heon;
    • Kim, Ju Sang;
    • Park, Jae Seuk;
    • Lee, Ji Yeon;
    • Kim, Song Yee;
    • Lee, Jae Ho;
    • Jo, Kyung-Wook;
    • Jhun, Byung Woo;
    • Kang, Young Ae;
    • Ahn, Joong Hyun;
    • Kim, Chang-Ki;
    • Shin, Soyoun;
    • Song, Taeksun
    Publication type:
    journal article
    49
    50